Thonzylamine
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | D04AA01 (WHO) R01AC06 (WHO) R06AC06 (WHO) |
Identifiers | |
| |
Synonyms | Neohetramine |
CAS Number |
91-85-0 ![]() |
PubChem (CID) | 5457 |
ChemSpider |
5258 ![]() |
UNII |
R79646H5Z8 ![]() |
KEGG |
D08587 ![]() |
ChEMBL |
CHEMBL1623738 ![]() |
ECHA InfoCard | 100.001.913 |
Chemical and physical data | |
Formula | C16H22N4O |
Molar mass | 286.372 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Thonzylamine (or neohetramine)[1] is an antihistamine and anticholinergic used as an antipruritic.
Synthesis

Thonzylamine synthesis: H. L. Friedman and A, V. Tolstouhov, U.S. Patent 2,465,865 (1949).
See also
References
Antihistamines for topical use | |
---|---|
Anesthetics for topical use | |
Others |
|
Decongestants and other nasal preparations (R01) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Topical |
| ||||||||||||||
Systemic use: Sympathomimetics |
Aminoalkyl ethers |
|
---|---|
Substituted alkylamines | |
Substituted ethylenediamines |
|
Phenothiazine derivatives | |
Piperazine derivatives | |
Others for systemic use |
|
For topical use |
Receptor (ligands) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (inhibitors) |
| ||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||
Others |
|
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.